A Dual-Modality MR/PA Imaging Contrast Agent Based on Ultrasmall Biopolymer Nanoparticles for Orthotopic Hepatocellular Carcinoma Imaging

References

• Waghray A, Murali AR, Menon KVN. Hepatocellular carcinoma: from diagnosis to treatment. World J Hepatol. 2015;7(8):1020–1029. doi:10.4254/wjh.v7.i8.102026052391
   PubMedGoogle Scholar
• Lu C, Ji J, Zhu X, et al. T2-weighted magnetic resonance imaging of hepatic tumor guided by SPIO-loaded nanostructured lipid carriers and ferritin reporter genes. ACS Appl Mater Interfaces. 2017;9(41):35548–35561. doi:10.1021/acsami.7b0987928944659
   PubMedGoogle Scholar
• Lu J, Sun J, Li F, et al. Highly sensitive diagnosis of small hepatocellular carcinoma using pH-responsive iron oxide nanocluster assemblies. J Am Chem Soc. 2018;140(32):10071–10074. doi:10.1021/jacs.8b0416930059219
   PubMedGoogle Scholar
• Lee YJ, Lee JM, Lee JS, et al. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging – a systematic review and meta-analysis. Radiology. 2015;275(1):97–109. doi:10.1148/radiol.1414069025559230
   PubMed Web of Science ®Google Scholar
• Chen R, Ling D, Zhao L, et al. Parallel comparative studies on mouse toxicity of oxide nanoparticle- and gadolinium-based T1 MRI contrast agents. ACS Nano. 2015;9(12):12425–12435. doi:10.1021/acsnano.5b0578326567968
   PubMed Web of Science ®Google Scholar
• Xu W, Sun J, Li L, Peng X, Zhang R, Wang B. Melanin-manganese nanoparticles with ultrahigh efficient clearance in vivo for tumor-targeting T1 magnetic resonance imaging contrast agent. Biomater Sci. 2018;6(1):207–215. doi:10.1039/C7BM00635G
   Web of Science ®Google Scholar
• Xue S, Yang H, Qiao J, et al. Protein MRI contrast agent with unprecedented metal selectivity and sensitivity for liver cancer imaging. Proc Natl Acad Sci. 2015;112(21):6607–6612. doi:10.1073/pnas.142302111225971726
   PubMedGoogle Scholar
• Cao Y, Liu M, Zhang K, et al. Poly(glycerol) used for constructing mixed polymeric micelles as T1 MRI contrast agent for tumor-targeted imaging. Biomacromolecules. 2017;18(1):150−158. doi:10.1021/acs.biomac.6b0143728064499
   PubMedGoogle Scholar
• Baek AR, Kim HK, Park S, et al. Gadolinium complex of 1,4,7,10-tetraazacyclododecane-1,4,7-trisacetic acid (DO3A)–ethoxybenzyl (EOB) conjugate as a new macrocyclic hepatobiliary MRI contrast agent. J Med Chem. 2017;60(12):4861−4868. doi:10.1021/acs.jmedchem.7b0006028530407
   PubMedGoogle Scholar
• Wang L, Lin H, Ma L, et al. Albumin-based nanoparticles loaded with hydrophobic gadolinium chelates as T1–T2 dual-mode contrast agents for accurate liver tumor imaging. Nanoscale. 2017;9(13):4516–4523. doi:10.1039/C7NR01134B28317976
   PubMed Web of Science ®Google Scholar
• Guo C, Sun L, She W, et al. A dendronized heparin–gadolinium polymer self-assembled into a nanoscale system as a potential magnetic resonance imaging contrast agent. Polym Chem. 2016;7(14):2531–2541. doi:10.1039/C6PY00059B
   Web of Science ®Google Scholar
• Cao Y, Xu L, Kuang Y, Xiong D, Pei R. Gadolinium-based nanoscale MRI contrast agents for tumor imaging. J Mater Chem B. 2017;5(19):3431–3461. doi:10.1039/C7TB00382J
   PubMed Web of Science ®Google Scholar
• Santelli J, Lechevallier S, Baaziz H, et al. Multimodal gadolinium oxysulfide nanoparticles: a versatile contrast agent for mesenchymal stem cell labeling. Nanoscale. 2018;10(35):16775–16786. doi:10.1039/C8NR03263G30156241
   PubMedGoogle Scholar
• Chen H, Li X, Liu F, Zhang H, Wang Z. Renal clearable peptide functionalized NaGdF4 nanodots for high-efficiency tracking orthotopic colorectal tumor in mouse. Mol Pharmaceutics. 2017;14(9):3134–3141. doi:10.1021/acs.molpharmaceut.7b00361
   PubMed Web of Science ®Google Scholar
• Judenhofer MS, Wehrl HF, Newport DF, et al. Simultaneous PET–MRI: a new approach for functional and morphological imaging. Nat Med. 2008;14(4):459–465. doi:10.1038/nm170018376410
   PubMedGoogle Scholar
• Lemaster JE, Wang Z, Hariri A, et al. Gadolinium doping enhances the photoacoustic signal of synthetic melanin nanoparticles: a dual modality contrast agent for stem cell imaging. Chem Mater. 2019;31(1):251–259. doi:10.1021/acs.chemmater.8b04333
   PubMed Web of Science ®Google Scholar
• Nie L, Wang S, Wang X, et al. In vivo volumetric photoacoustic molecular angiography and therapeutic monitoring with targeted plasmonic nanostars. Small. 2014;10(8):1585–1593. doi:10.1002/smll.20130292424150920
   PubMed Web of Science ®Google Scholar
• Liu Y, Nie L, Chen X. Photoacoustic molecular imaging: from multiscale biomedical applications towards early-stage theranostics. Trends Biotechnol. 2016;34(5):420–433. doi:10.1016/j.tibtech.2016.02.00126924233
   PubMedGoogle Scholar
• Jiang X, Zhang S, Ren F, et al. Ultrasmall magnetic CuFeSe2 ternary nanocrystals for multimodal imaging guided photothermal therapy of cancer. ACS Nano. 2017;11(6):5633–5645. doi:10.1021/acsnano.7b0103228525715
   PubMed Web of Science ®Google Scholar
• Yang W, Guo W, Le W, et al. Albumin-bioinspired Gd:CuS nanotheranostic agent for in vivo photoacoustic/magnetic resonance imaging-guided tumor-targeted photothermal therapy. ACS Nano. 2016;10(11):10245–10257. doi:10.1021/acsnano.6b0576027791364
   PubMed Web of Science ®Google Scholar
• Liang X, Li Y, Li X, et al. PEGylated polypyrrole nanoparticles conjugating gadolinium chelates for dual-modal MRI/photoacoustic imaging guided photothermal therapy of cancer. Adv Funct Mater. 2015;25(9):1451–1462. doi:10.1002/adfm.v25.9
   Web of Science ®Google Scholar
• Cheng Y, Tan X, Wang J, et al. Polymer-based gadolinium oxide nanocomposites for FL/MR/PA imaging guided and photothermal/photodynamic combined anti-tumor therapy. J Control Release. 2018;277:77–88. doi:10.1016/j.jconrel.2018.03.00929526740
   PubMed Web of Science ®Google Scholar
• Lv X, Wang X, Li T, et al. Rationally designed monodisperse Gd2O3/Bi2S3 hybrid nanodots for efficient cancer theranostics. Small. 2018;14(49):1802904. doi:10.1002/smll.v14.49
   Web of Science ®Google Scholar
• Pan J, Zhu X, Chen X, Zhao Y, Liu J. Gd3+-doped MoSe2 nanosheets used as a theranostic agent for bimodal imaging and highly efficient photothermal cancer therapy. Biomater Sci. 2018;6(2):372–387. doi:10.1039/C7BM00894E29334095
   PubMedGoogle Scholar
• Liu Y, Ai K, Ji X, et al. Comprehensive insights into the multi-antioxidative mechanisms of melanin nanoparticles and their application to protect brain from injury in ischemic stroke. J Am Chem Soc. 2017;139(2):856–862. doi:10.1021/jacs.6b1101327997170
   PubMedGoogle Scholar
• Zhang R, Fan Q, Yang M, et al. Engineering melanin nanoparticles as an efficient drug-delivery system for imaging-guided chemotherapy. Adv Mater. 2015;27(34):5063–5069. doi:10.1002/adma.20150220126222210
   PubMed Web of Science ®Google Scholar
• Qi C, Fu L, Xu H, Wang T, Lin J, Huang P. Melanin/polydopamine-based nanomaterials for biomedical applications. Sci China Chem. 2019;62(2):162–188. doi:10.1007/s11426-018-9392-6
   Web of Science ®Google Scholar
• Ju KY, Lee JW, Im GH, et al. Bio-inspired, melanin-like nanoparticles as a highly efficient contrast agent for T1-weighted magnetic resonance imaging. Biomacromolecules. 2013;14(10):3491−3497. doi:10.1021/bm400813823987128
   PubMedGoogle Scholar
• Wang Y, Huang Q, He X, et al. Multifunctional melanin-like nanoparticles for bone-targeted chemo-photothermal therapy of malignant bone tumors and osteolysis. Biomaterials. 2018;183:10–19. doi:10.1016/j.biomaterials.2018.08.03330144589
   PubMed Web of Science ®Google Scholar
• Fan Q, Cheng K, Hu X, et al. Transferring biomarker into molecular probe: melanin nanoparticle as a naturally active platform for multimodality imaging. J Am Chem Soc. 2014;136(43):15185−15194. doi:10.1021/ja505412p25292385
   PubMed Web of Science ®Google Scholar
• Zhang L, Su H, Cai J, et al. A multifunctional platform for tumor angiogenesis-targeted chemo-thermal therapy using polydopamine-coated gold nanorods. ACS Nano. 2016;10(11):10404−10417. doi:10.1021/acsnano.6b0626727934087
   PubMed Web of Science ®Google Scholar
• Meredith P, Powell BJ, Riesz J, Nighswander-Rempel SP, Pederson MR, Moore EG. Towards structure–property–function relationships for eumelanin. Soft Matter. 2006;2(1):37−44. doi:10.1039/B511922G
   PubMed Web of Science ®Google Scholar
• Cho S, Park W, Kim D. Silica-coated metal chelating-melanin nanoparticles as a dual-modal contrast enhancement imaging and therapeutic agent. ACS Appl Mater Interfaces. 2017;9(1):101−111.27992171
   PubMed Web of Science ®Google Scholar
• Zhou Z, Wu C, Liu H, et al. Surface and interfacial engineering of iron oxide nanoplates for highly efficient magnetic resonance angiography. ACS Nano. 2015;9(3):3012–3022. doi:10.1021/nn507193f25670480
   PubMed Web of Science ®Google Scholar
• Vilgrain V, Beers BEV, Pastor CM. Insights into the diagnosis of hepatocellular carcinomas with hepatobiliary MRI. J Hepatol. 2016;64(3):708−716. doi:10.1016/j.jhep.2015.11.01626632635
   PubMedGoogle Scholar
• Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Controlled Release. 2010;148(2):135–146. doi:10.1016/j.jconrel.2010.08.027
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011;63(3):136–151. doi:10.1016/j.addr.2010.04.00920441782
   PubMed Web of Science ®Google Scholar
• Zhang S, Chu Z, Yin C, Zhang C, Lin G, Li Q. Controllable drug release and simultaneously carrier decomposition of SiO2-drug composite nanoparticles. J Am Chem Soc. 2013;135(15):5709–5716. doi:10.1021/ja312301523496255
   PubMed Web of Science ®Google Scholar
• Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine. 2008;3(5):703–717. doi:10.2217/17435889.3.5.70318817471
   PubMed Web of Science ®Google Scholar